UPDATE 6-Roche stock up $12 bln on cancer, haemophilia trials; rivals hit
November 20, 2017 at 11:03 AM EST
* Roche playing catch-up in cancer immunotherapy (Adds latest stock falls for rivals)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.